Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov 24:(93):e52232.
doi: 10.3791/52232.

Handling of the cotton rat in studies for the pre-clinical evaluation of oncolytic viruses

Breanne Cuddington  1 , Meghan Verschoor  1 , Karen Mossman  2
Affiliations

Handling of the cotton rat in studies for the pre-clinical evaluation of oncolytic viruses

Breanne Cuddington et al. J Vis Exp. .

Abstract

Oncolytic viruses are a novel anticancer therapy with the ability to target tumor cells, while leaving healthy cells intact. For this strategy to be successful, recent studies have shown that involvement of the host immune system is essential. Therefore, oncolytic virotherapy should be evaluated within the context of an immunocompetent model. Furthermore, the study of antitumor therapies in tolerized animal models may better recapitulate results seen in clinical trials. Cotton rats, commonly used to study respiratory viruses, are an attractive model to study oncolytic virotherapy as syngeneic models of mammary carcinoma and osteosarcoma are well established. However, there is a lack of published information on the proper handling procedure for these highly excitable rodents. The handling and capture approach outlined minimizes animal stress to facilitate experimentation. This technique hinges upon the ability of the researcher to keep calm during handling and perform procedures in a timely fashion. Finally, we describe how to prepare cotton rat mammary tumor cells for consistent subcutaneous tumor formation, and how to perform intratumoral and intraperitoneal injections. These methods can be applied to a wide range of studies furthering the development of the cotton rat as a relevant pre-clinical model to study antitumor therapy.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Cervantes-Garcia D, Ortiz-Lopez R, Mayek-Perez N, Rojas-Martinez A. Oncolytic virotherapy. Ann Hepatol. 2008;7(1):34–45. - PubMed
    1. Vaha-Koskela MJ, Heikkila JE, Hinkkanen AE. Oncolytic viruses in cancer therapy. Cancer Lett. 2007;254(2):178–216. - PMC - PubMed
    1. Abril C, et al. Both viral and host factors contribute to neurovirulence of bovine herpesviruses 1 and 5 in interferon receptor-deficient mice. J Virol. 2004;78(7):3644–3653. - PMC - PubMed
    1. Nakamichi K, Matsumoto Y, Otsuka H. Defective infection of bovine herpesvirus 1 in non-permissive murine cells. J Vet Med Sci. 2001;63(10):1139–1142. - PubMed
    1. Boukhvalova MS, Blanco JC. The cotton rat sigmodon hispidus model of respiratory syncytial virus infection. Curr Top Microbiol Immunol. 2013;372:347–358. - PubMed

Publication types

LinkOut - more resources